PL358304A1 - Thrombopoietin receptor modulating peptide - Google Patents

Thrombopoietin receptor modulating peptide

Info

Publication number
PL358304A1
PL358304A1 PL01358304A PL35830401A PL358304A1 PL 358304 A1 PL358304 A1 PL 358304A1 PL 01358304 A PL01358304 A PL 01358304A PL 35830401 A PL35830401 A PL 35830401A PL 358304 A1 PL358304 A1 PL 358304A1
Authority
PL
Poland
Prior art keywords
receptor modulating
thrombopoietin receptor
modulating peptide
peptide
thrombopoietin
Prior art date
Application number
PL01358304A
Other languages
Polish (pl)
Inventor
Tatjana Naranda
Lennart Olsson
Original Assignee
Pliva, Farmaceutska Industrija, Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva, Farmaceutska Industrija, Dionicko Drustvo filed Critical Pliva, Farmaceutska Industrija, Dionicko Drustvo
Publication of PL358304A1 publication Critical patent/PL358304A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL01358304A 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide PL358304A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Publications (1)

Publication Number Publication Date
PL358304A1 true PL358304A1 (en) 2004-08-09

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01358304A PL358304A1 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Country Status (24)

Country Link
US (1) US20030181659A1 (en)
EP (2) EP1149906A1 (en)
JP (1) JP2003530867A (en)
KR (1) KR20030009450A (en)
CN (1) CN1426467A (en)
AR (1) AR030278A1 (en)
AU (2) AU6736601A (en)
BG (1) BG107214A (en)
BR (1) BR0110383A (en)
CA (1) CA2407167A1 (en)
CZ (1) CZ20023517A3 (en)
EA (1) EA006423B1 (en)
EE (1) EE200200610A (en)
GE (1) GEP20063763B (en)
HU (1) HUP0300559A3 (en)
IL (1) IL152204A0 (en)
IS (1) IS6582A (en)
MX (1) MXPA02010458A (en)
NO (1) NO20025114L (en)
PL (1) PL358304A1 (en)
SK (1) SK15262002A3 (en)
WO (1) WO2001080873A2 (en)
YU (1) YU79202A (en)
ZA (1) ZA200208662B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002359362A1 (en) * 2001-11-07 2003-05-19 Millennium Pharmaceuticals, Inc. Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
KR20050093759A (en) * 2002-09-18 2005-09-23 오르토-맥네일 파마슈티칼, 인코퍼레이티드 Methods of increasing platelet and hematopoietic stem cell production
CN1739017B (en) 2002-12-11 2011-04-06 弗罗桑医疗设备公司 Gelatin-based material used as a swab
WO2004100997A2 (en) * 2003-05-12 2004-11-25 Affymax, Inc. Spacer moiety for poly(ethylene glycol) -modified peptides
JP2007530440A (en) * 2003-05-12 2007-11-01 アフィーマックス・インコーポレイテッド Novel poly (ethylene glycol) modified compounds and uses thereof
JP2005187435A (en) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd Thrombocyte production promoting composition
WO2005072700A2 (en) 2004-01-30 2005-08-11 Ferrosan A/S Haemostatic sprays and compositions
AU2005262070B2 (en) 2004-07-09 2011-01-27 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
CA2641189A1 (en) * 2006-01-31 2007-08-09 Mitsubishi Kagaku Iatron, Inc. Method for determination of condition of disseminated intravascular coagulation syndrome
CN102014973A (en) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 Device for promotion of hemostasis and/or wound healing
EP2708597B1 (en) * 2011-05-13 2017-11-15 The University of Tokyo Polynucleated megakaryocytic cell and method for manufacturing platelets
RU2657955C2 (en) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Pressurised container containing haemostatic paste
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (en) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス Dry composition containing an extrusion enhancing factor
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
RU2705905C2 (en) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Syringe for holding and mixing first and second substances
CN107771093B (en) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 Syringe for mixing two components and for maintaining vacuum under storage conditions
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
WO2026005476A1 (en) * 2024-06-26 2026-01-02 주식회사 넥스세라 Recombinant protein for treating thrombocytopenia, and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
WO1996040189A1 (en) * 1995-06-07 1996-12-19 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
JP2002508160A (en) * 1998-02-24 2002-03-19 レセプトロン，インコーポレイティド Receptor-derived peptides as modulators of receptor activity

Also Published As

Publication number Publication date
HUP0300559A3 (en) 2005-09-28
WO2001080873A3 (en) 2002-01-31
AR030278A1 (en) 2003-08-20
AU6736601A (en) 2001-11-07
JP2003530867A (en) 2003-10-21
CN1426467A (en) 2003-06-25
KR20030009450A (en) 2003-01-29
GEP20063763B (en) 2006-03-10
SK15262002A3 (en) 2003-05-02
EP1149906A1 (en) 2001-10-31
CZ20023517A3 (en) 2003-10-15
WO2001080873A2 (en) 2001-11-01
US20030181659A1 (en) 2003-09-25
EA006423B1 (en) 2005-12-29
BG107214A (en) 2003-11-28
IL152204A0 (en) 2003-05-29
EP1278849A2 (en) 2003-01-29
ZA200208662B (en) 2003-10-27
BR0110383A (en) 2003-01-21
AU2001267366B2 (en) 2005-06-30
IS6582A (en) 2002-10-14
MXPA02010458A (en) 2003-06-06
NO20025114L (en) 2002-12-18
EA200201138A1 (en) 2003-06-26
YU79202A (en) 2006-01-16
CA2407167A1 (en) 2001-11-01
AU2001267366B9 (en) 2005-07-14
HUP0300559A2 (en) 2003-06-28
EE200200610A (en) 2004-08-16
NO20025114D0 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
HUP0300559A3 (en) Thrombopoietin receptor modulating peptide
GB0014870D0 (en) Peptides
GB0029777D0 (en) Peptides
AU6268901A (en) Oligopeptides
GB0015761D0 (en) Polypeptide
GB0000474D0 (en) Receptor
GB0127017D0 (en) New polypeptide
AU1252102A (en) Receptor
GB0001825D0 (en) Peptides
GB0121215D0 (en) Polypeptide
HK1054406A (en) Thrombopoietin receptor modulating peptide
GB0025572D0 (en) New polypeptide
GB0007263D0 (en) Peptides
GB0127028D0 (en) New polypeptide
GB2388486B (en) Projection unit
GB0013239D0 (en) Polypeptide
EP1323731A4 (en) Novel peptides
GB0012199D0 (en) New polypeptide
GB0027989D0 (en) Modulator
GB0020946D0 (en) Modulator
GB0021475D0 (en) Anti-aniogenic peptides
GB0007264D0 (en) Peptides
GB0010327D0 (en) Peptides
GB0001826D0 (en) Peptides
AU1790P (en) Jabiru Glycine max

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)